TGFBR2 and ovarian carcinoma: In a meta-analysis of the genomic profiles from 1525 ovarian cancer samples, overexpression of TβRII was part of a highly specific gene signature differentiating suboptimal versus optimally debulked patients undergoing primary cytoreductive surgery.